Qidni Labs
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$550k | Seed | ||
* | N/A | Seed | |
N/A | N/A | Early VC | |
* | N/A | Grant | |
* | N/A | $730k | Seed |
Total Funding | €1.2m |
Related Content
Recent News about Qidni Labs
EditQidni Labs is a pioneering medical technology company focused on developing an implantable renal replacement therapy for patients suffering from End Stage Renal Disease (ESRD). The company aims to revolutionize the current dialysis market by offering a continuous and accessible alternative to traditional dialysis treatments. Qidni Labs serves patients, healthcare providers, and insurance companies by providing a cost-effective solution that reduces the need for expensive dialysis equipment and caregiving services. The business operates in the medical technology sector, targeting a global market of over two million ESRD patients. Qidni Labs generates revenue through the sale of its implantable devices and associated services. The company's innovative approach not only aims to improve patient survival rates but also to alleviate the financial burden on the healthcare system.
Keywords: renal replacement therapy, ESRD, dialysis, implantable device, medical technology, healthcare, cost-effective, patient survival, continuous treatment, global market.